Medchemexpress LLC Imatinib Mesylate | 220127-57-1 | 99.9% | C30H35N7O4S | 10 MM 1 ML

Supplier:  Medchemexpress LLC HY5094610MM/1ML

Imatinib Mesylate (STI571 Mesylate) is an orally active tyrosine kinase inhibitor. It inhibits c-Kit, Bcr-Abl, and PDGFR with an IC50 of 100 nM.

• Orally active tyrosine kinase inhibitor.
• Inhibits c-Kit, Bcr-Abl, and PDGFR with an IC50 of 100 nM.
• Cited in over 115 publications.
• Used in research for cancer, infection, neurological disease, and inflammation/immunology.
• Targets include c-Kit, Bcr-Abl, PDGFR, and Autophagy.
• Active in Protein Tyrosine Kinase/RTK and Autophagy pathways.

Catalog No. 50-003-58179